S.Giri Pathmanaban

Giri's experience includes:

• Oasis Tooling Inc. v. GlobalFoundries: Represented GlobalFoundries (GF) in a patent litigation brought by Oasis. Was the day-to-day partner in charge of running a massive patent litigation against GF, which sought $400million. The court granted summary judgment in favor of GF.
• Represented Overhead Door in multi-patent competitor cases against Chamberlain Group, Inc. Case settled on highly favorable terms after the ITC issued a judgment of infringement on three patents. 
• Represented Amphenol in its dispute with competitor PPC. Argued final hearing at PTAB which led to invalidating all four of PPC’s patents
• Represented Monsanto in multi- patent competitor cases against DuPont involved corn seed breeding technology
• Defended Abbott in a patent infringement lawsuit brought by competitor relating to wireless heart monitoring device, called CardioMEMs. ISS alleged that CardioMEMs was a rip-off; successfully filed IPRs and forced ISS to dismiss its case voluntarily
• Represented Amazon.com in dispute related to automated pricing technology—court granted motion to dismiss
• Delphix Corp. v. Actifio, Inc. (N.D. Cal.) (D. Mass) Represented Actifio in a massive trade secret and nine-patent case involving two jurisdictions. Giri argued final hearings at the PTAB that invalidated all of Delphix’s patents. Case settled favorably afterwards
• FlexStent v. Abbott (C.D. Cal.) (Fed. Cir.) Defended Abbott in a patent infringement lawsuit in the Central District of California. Flexstent alleged that Abbott’s Xience stents, the best-selling drug-eluting stents on the market, infringes its patent. Abbott filed an inter partes review petition with the patent office seeking to invalidate the patent and got the PTAB to agree. FlexStent appealed but the Federal Circuit issued a Rule 36 affirmance—a total victory
• Edwards v. Abbott (C.D. Cal.) Defended Abbott in a patent infringement lawsuit brought by competitor, Edwards Lifesciences, in the US District Court for the Central District of California. Edwards alleged that Abbott’s MitraClip, the only FDA-approved transcatheter-based mitral repair device on the market, infringes three patents. MitraClip is one of Abbott’s flagship products, with sales exceeding over US$400 million a year. Abbott filed two IPRs, and in response, Edwards dropped all challenged claims, handing a huge victory to Abbott. Case settled on highly favorable terms
• United Video Properties, Inc. v. Amazon.com (Fed. Cir.): Drafted brief and helped prepare for oral argument for Amazon, and helped secure affirmance of non- infringement by Federal Circuit

Speaking Engagements

• Speaker, “What Phillips Wrought: Trends in Claim Construction Law and Procedure, “Advanced Patent Litigation Seminar, State Bar of Texas, March 23, 2012

Publications

• “PTAB Update: New Motion to Amend Procedures Proposed,” Latham & Watkins Client Alert, October 30, 2018 
• “En Banc Federal Circuit Overturns PTAB’s IPR Time-Bar Ruling,” Latham & Watkins Client Alert, August 23, 2018
• “Patent Owner Statements During IPR May Limit Claim Scope,” Latham & Watkins Client Alert, June 6, 2017
• “PTO Issues New Final Rules for PTAB Proceedings,” Latham & Watkins Client Alert, March 31, 2016